Authors:
Helske, S
Vuorela, P
Carpen, O
Hornig, C
Weich, H
Halmesmaki, E
Citation: S. Helske et al., Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies, MOL HUM REP, 7(2), 2001, pp. 205-210
Authors:
Boldicke, T
Tesar, M
Griesel, C
Rohde, M
Grone, HJ
Waltenberger, J
Kollet, G
Lapidot, T
Yayon, A
Weich, H
Citation: T. Boldicke et al., Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizingthe human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) onthe surface of primary endothelial cells and preselected. CD34(+) cells from cord blood, STEM CELLS, 19(1), 2001, pp. 24-36
Authors:
Hecht, HJ
Adar, R
Hofmann, B
Bogin, O
Weich, H
Yayon, A
Citation: Hj. Hecht et al., Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces, ACT CRYST D, 57, 2001, pp. 378-384
Authors:
Neulen, J
Wenzel, D
Hornig, C
Wunsch, E
Weissenborn, U
Grunwald, K
Buttner, R
Weich, H
Citation: J. Neulen et al., Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols, HUM REPR, 16(4), 2001, pp. 621-626
Authors:
Vuorela, P
Helske, S
Hornig, C
Alitalo, K
Weich, H
Halmesmaki, E
Citation: P. Vuorela et al., Amniotic fluid-soluble vascular endothelial growth factor receptor-1 in preeclampsia, OBSTET GYN, 95(3), 2000, pp. 353-357
Authors:
Bussolino, F
Claesson-Welsh, L
Grandi, M
Zichi, M
Maragoudakis, M
Weich, H
Alitalo, K
Lampugnani, MG
Harris, A
Citation: F. Bussolino et al., Molecular mechanisms of angiogenesis associated to cancer progression: Targets for new diagnostic tools and for new anticancer therapeutic approaches, BIOM HLTH R, 24, 1998, pp. 117-121